Events
MAR 12
MAR 01
FEB 28
Leadership Spotlight
Dr. Jonathan Zalevsky, Chief Scientific Officer discusses bempegaldesleukin (NKTR-214)
Latest News
OUR PIPELINE
We are focused on using new chemistry approaches to make better medicines to treat cancer, chronic pain and auto-immune disease.
Cutting-edge facilities
Dynamic teams
Impactful work
OUR Culture
We are supported by a dynamic team, rich in scientific, business and medical expertise, across three locations.